Advances In Cirrhosis, Hyperammonemia, And Hepatic Encephalopathy (advances In Experimental Medicine And Biology) (volume 420)

Brain Tryptophan Perturbation in Hepatic Encephalopathy: Implications for Effects by Neuropsychoactive Drugs in Clinical Practice; F. Bengtsson, et al. Hepatic Encephalopathy in Acute Liver Failure: Role of the Glutamate System; A. Michalak, et al. Glutamate and Muscarinic Receptors in the Molecular Mechanisms of Acute Ammonia Toxicity and of Its Prevention; M.D. Miñana, et al. Studies on the Pharmacological Properties of Oxindole (2-Hydroxyindole) and 5-Hydroxyindole: Are They Involved in Hepatic Encephalopathy?; F. Moroni, et al. The Involvement of Ammonia with the Mechanisms That Enhance GABA-ergic Neurotransmission in Hepatic Failure; E.A. Jones, A.S. Basile. Direct Enhancement of GABA-ergic Neurotransmission by Ammonia; J.-H. Ha, et al. The Peripheral Benzodiazepine Receptor and Neurosteroids in Hepatic Encephalopathy; M.D. Norenberg, et al. Ornithine Aminotransferase as a Therapeutic Target in Hyperammonemias; N. Seiler. Sparse-Fur (spf) Mouse as a Model of Hyperammonemia: Alterations in the Neurotransmitter Systems; I.A. Qureshi, K.V.R. Rao. Abnormal Gene Expression Causing Hyperammonemia in Carnitine-Deficient Juvenile Visceral Steatosis (JVS) Mice; T. Saheki, et al. 7 Additional Articles. Index. Front Matter....Pages i-viii Brain Tryptophan Perturbation in Hepatic Encephalopathy: Implications for Effects by Neuropsychoactive Drugs in Clinical Practice....Pages 1-33 Hepatic Encephalopathy in Acute Liver Failure: Role of the Glutamate System....Pages 35-43 Glutamate and Muscarinic Receptors in the Molecular Mechanisms of Acute Ammonia Toxicity and of Its Prevention....Pages 45-56 Studies on the Pharmacological Properties of Oxindole (2-Hydroxyindole) and 5-Hydroxyindole: Are They Involved in Hepatic Encephalopathy?....Pages 57-73 The Involvement of Ammonia with the Mechanisms that Enhance Gaba-Ergic Neurotransmission in Hepatic Failure....Pages 75-83 Direct Enhancement of Gaba-Ergic Neurotransmission by Ammonia....Pages 85-94 The Peripheral Benzodiazepine Receptor and Neurosteroids in Hepatic Encephalopathy....Pages 95-111 Ornithine Aminotransferase as a Therapeutic Target in Hyperammonemias....Pages 113-142 Sparse-Fur (spf) Mouse as a Model of Hyperammonemia: Alterations in the Neurotransmitter Systems....Pages 143-158 Abnormal Gene Expression Causing Hyperammonemia in Carnitine-Deficient Juvenile Visceral Steatosis (JVS) Mice....Pages 159-172 Hyperammonaemia without Portal Systemic Shunting Does Not Resemble Hepatic Encephalopathy....Pages 173-183 Magnetic Resonance Spectroscopy in the Study of Hyperammonemia and Hepatic Encephalopathy....Pages 185-194 Osmosignalling and Osmolytes in Liver and Astrocytes....Pages 195-215 Effects of Acid-Base Alterations and Protein Depletion on Hepatic Nitrogen Metabolism....Pages 217-227 Glucose and Insulin Metabolism in Cirrhosis....Pages 229-233 An Ammonia Hypothesis of Alzheimer Disease....Pages 235-255 Living Related Liver Transplantation....Pages 257-266 Back Matter....Pages 267-281 Brain Tryptophan Perturbation in Hepatic Encephalopathy: Implications for Effects by Neuropsychoactive Drugs in Clinical Practice; __Bengtsson, et al.____A. Michalak, et al.____M.D. Miñana, et al.____F.__ The Involvement of Ammonia with the Mechanisms That Enhance GABA-ergic Neurotransmission in Hepatic Failure; __A.S. Basile.____J.-H. Ha, et al.____M.D. Norenberg, et al.____N. Seiler.____I.A. Qureshi, K.V.R. Rao.____T. Saheki, et al.__ Proceedings of an international symposiu, held in Valencia, Spain, December 2-4, 1996